Cargando…

Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab

INTRODUCTION: Adverse drug reactions (ADRs) are associated with significant health-related and financial burden, and multiple sources are currently utilized to actively discover them. Social media has been proposed as a potential resource for monitoring ADRs, but drug-specific analytical studies com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Karen, Golder, Su, Sarker, Abeed, Loke, Yoon, O’Connor, Karen, Gonzalez-Hernandez, Graciela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223697/ https://www.ncbi.nlm.nih.gov/pubmed/30167992 http://dx.doi.org/10.1007/s40264-018-0707-6

Ejemplares similares

Promoting Reproducible Research for Characterizing Nonmedical Use of Medications Through Data Annotation: Description of a Twitter Corpus and Guidelines
por: O'Connor, Karen, et al.
Publicado: (2020)

Using Twitter Data for Cohort Studies of Drug Safety in Pregnancy: Proof-of-concept With β-Blockers
por: Klein, Ari Z, et al.
Publicado: (2022)

Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter
por: Sarker, Abeed, et al.
Publicado: (2016)

Toward Using Twitter Data to Monitor COVID-19 Vaccine Safety in Pregnancy: Proof-of-Concept Study of Cohort Identification
por: Klein, Ari Z, et al.
Publicado: (2022)

Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database
por: Kimura, Goji, et al.
Publicado: (2015)

Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database
por: Hirai, Risako, et al.
Publicado: (2023)

Methods to Establish Race or Ethnicity of Twitter Users: Scoping Review
por: Golder, Su, et al.
Publicado: (2022)

Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features
por: Nikfarjam, Azadeh, et al.
Publicado: (2015)

The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review
por: Golder, Su, et al.
Publicado: (2023)

Comment on: “Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts”
por: Magge, Arjun, et al.
Publicado: (2019)

Assessment of Beliefs and Attitudes About Statins Posted on Twitter: A Qualitative Study
por: Golder, Su, et al.
Publicado: (2020)

A corpus for mining drug-related knowledge from Twitter chatter: Language models and their utilities
por: Sarker, Abeed, et al.
Publicado: (2016)

Public Perspectives on Anti-Diabetic Drugs: Exploratory Analysis of Twitter Posts
por: Golder, Su, et al.
Publicado: (2021)

A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews
por: Golder, Su, et al.
Publicado: (2020)

Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
por: Zhou, Jianxing, et al.
Publicado: (2022)

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
por: Zhao, Hui, et al.
Publicado: (2023)

Towards scaling Twitter for digital epidemiology of birth defects
por: Klein, Ari Z., et al.
Publicado: (2019)

Extending A Chronological and Geographical Analysis of Personal Reports of COVID-19 on Twitter to England, UK
por: Golder, S, et al.
Publicado: (2020)

A chronological and geographical analysis of personal reports of COVID-19 on Twitter from the UK
por: Golder, Su, et al.
Publicado: (2022)

Analysis of Adverse Reactions of Aspirin in Prophylaxis Medication Based on FAERS Database
por: Ren, Weidong, et al.
Publicado: (2022)

Quality of reporting in systematic reviews of adverse events: systematic review
por: Zorzela, Liliane, et al.
Publicado: (2014)

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
por: Fusaroli, Michele, et al.
Publicado: (2022)

Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data
por: Al-Azzawi, Fahed, et al.
Publicado: (2023)

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
por: Zou, Shu-peng, et al.
Publicado: (2023)

Advances in Text Mining and Visualization for Precision Medicine
por: Gonzalez-Hernandez, Graciela, et al.
Publicado: (2018)

Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database
por: Guo, Mingxing, et al.
Publicado: (2022)

Safety Profile of Levonorgestrel: A Disproportionality Analysis of Food and Drug Administration Adverse Event Reporting System (Faers) Database
por: Kurian, Anitha, et al.
Publicado: (2018)

Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019
por: Setyawan, Juliana, et al.
Publicado: (2021)

Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
por: Tian, Xiaojiang, et al.
Publicado: (2022)

Carfilzomib-induced Cardiotoxicity: An Analysis of the FDA Adverse Event Reporting System (FAERS)
por: Buck, Benjamin, et al.
Publicado: (2022)

Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS
por: Li, Meng, et al.
Publicado: (2022)

Public Perceptions About Monkeypox on Twitter: Thematic Analysis
por: Leslie, Abimbola, et al.
Publicado: (2023)

A Data-Driven Iterative Approach for Semi-automatically Assessing the Correctness of Medication Value Sets: A Proof of Concept Based on Opioids
por: Li, Linyi, et al.
Publicado: (2021)

A Survey of the FAERS Database Concerning the Adverse Event Profiles of α1-Adrenoreceptor Blockers for Lower Urinary Tract Symptoms
por: Yoshimura, Koji, et al.
Publicado: (2013)

Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
por: Ma, Zhuo, et al.
Publicado: (2021)

Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database
por: Shu, Yamin, et al.
Publicado: (2022)

Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
por: Zhou, Chaozheng, et al.
Publicado: (2023)

A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
por: Cui, Zhiwei, et al.
Publicado: (2023)

Deep neural networks ensemble for detecting medication mentions in tweets
por: Weissenbacher, Davy, et al.
Publicado: (2019)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m09aniujkrub0h5ktsi4ood29t